News
Tag: Financial & Investor News
-
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
Company to host conference call at 4:30 PM EDT today, May 12, 2022. SEATTLE, Wash and VANCOUVER, British Columbia, May 12, 2022 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced first quarter 2022 financial results…
-
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
SEATTLE, Wash and VANCOUVER, British Columbia, April 21, 2022 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will report its first quarter financial results and provide an update on the cytisinicline development program on Thursday,…
-
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update
Company to host conference call at 4:30 PM EST today, March 10, 2022. SEATTLE, Wash and VANCOUVER, British Columbia, March 10, 2022 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced fourth quarter and year-end 2021…
-
Achieve Life Sciences Announces Participation in March Investor Conferences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 8, 2022 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating in the Oppenheimer 32nd Annual Virtual Healthcare Conference and the Maxim 2022 Virtual Growth…
-
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022
SEATTLE, Wash and VANCOUVER, British Columbia, February 24, 2022 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will report its fourth quarter and year-end 2021 financial results and provide an update on the cytisinicline…